Integrative Hormone Care Plan to Address Imbalances

Integrative Hormone Care, Iron Physiology, SHBG, and Metabolic Context: Evidence-Based Strategies That Work in Real Clinics

Abstract

In this educational post, I synthesize current evidence from leading researchers and my clinical observations to guide clinicians and health-savvy patients through an integrative, chiropractic-informed approach to common hormone and metabolic challenges. We will explore iron deficiency in menstruating women and why copper balance and thyroid status matter; cyclic progesterone strategies to reduce heavy bleeding; special considerations for patients with PCOS and post-bariatric physiology; testosterone therapy principles (absorption, distribution, renal excretion), dose-response variability by BMI and kidney function, and practical management of transient estrogenic symptoms; risk-benefit decisions about contraceptives and DVT; the clinical realities of high sex hormone–binding globulin (SHBG) in midlife women; the difference between contraceptive progestins and bioidentical progesterone; and the role of integrative chiropractic care in restoring whole-person function. Throughout, I highlight how biomechanics, autonomic tone, micronutrient repletion, gut ecology, and strength training interface with endocrine protocols to improve outcomes.

By Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST

Introduction: Why an Integrative Lens Matters Now

Hormones never act in isolation. Their clinical expression is shaped by nutrient status, gut absorption, autonomic balance, body composition, sleep, and training load. In my practice, I see patterns repeat: iron deficiency amplifies fatigue and heavy bleeding; PCOS often rides alongside insulin resistance and altered gut ecology; transdermal and pellet testosterone behave differently across ranges of BMI and renal clearance; and SHBG can invisibly blunt symptom relief unless we address the “why.”

At WellnessDoctorRx, my team and I combine evidence-based endocrinology with integrative chiropractic care and functional medicine principles to optimize both inputs and outputs: we work on posture, joint mechanics, and vagal tone, while we refine micronutrient status, gut health, and hormone delivery. This bidirectional strategy is what consistently moves patients from “better labs” to better lives.

Iron Deficiency, Copper Balance, and Thyroid: The Foundational Triad

Key concepts

• Iron deficiency is common in menstruating women and frequently coexists with heavy menstrual bleeding, fatigue, and cognitive fog.
• Copper, ceruloplasmin, and iron handling are intertwined; thyroid function modulates erythropoiesis and iron transport.
• Addressing iron without fixing the bleed or thyroid status is a short-term patch.

Physiology in focus

• Iron transport and utilization depend on adequate ceruloplasmin, the copper-containing ferroxidase that converts Fe2+ to Fe3+ for loading onto transferrin. Low copper or low ceruloplasmin can impair the mobilization of stored iron, leaving ferritin normal or high while functional iron is low. This can present as fatigue despite “okay” iron stores.
• Thyroid hormones drive erythropoiesis and gastric acid production; hypothyroidism can reduce iron absorption via hypochlorhydria and slow marrow activity. Clinically, optimizing thyroid function can reduce anemia and improve response to iron therapy.
• Heavy uterine bleeding increases iron loss. Without controlling bleeding (often via cyclic progesterone), iron deficiency recurs.

Clinical approach I use

• Laboratory assessment:
  • CBC with indices, reticulocytes
  • Ferritin, iron, TIBC, transferrin saturation
  • Copper, ceruloplasmin, if discordance between ferritin and symptoms
  • TSH, free T4, free T3; consider thyroid antibodies
• Treatment sequence:
  • Stabilize bleeding with cyclic progesterone (see next section).
  • Replete iron using oral ferrous bisglycinate or ferrous sulfate with vitamin C; consider alternate-day dosing to improve absorption and reduce hepcidin spikes.
  • Evaluate and replenish copper when indicated; avoid excessive zinc, which can depress copper.
  • Normalize thyroid function using evidence-based protocols; euthyroid status enhances iron absorption and utilization.
• Integrative chiropractic fit
  • Address thoracic mobility and diaphragmatic mechanics to improve vagal tone and GI motility; better parasympathetic tone supports gastric acidity and mineral absorption.
  • Breathing drills and rib mobilization can meaningfully improve digestive efficiency in patients with sympathetic overdrive.

Cyclic Progesterone to Tame Heavy Bleeding: Protocol Logic and Physiology

Why cyclic progesterone

• In anovulatory or luteal-insufficient cycles, unopposed estrogen thickens the endometrium. Progesterone stabilizes and organizes endometrial tissue, reduces prostaglandin-driven hypercontractility, and decreases bleeding volume and pain.

Protocols I employ and why

• For heavy bleeding: oral micronized progesterone 200 mg nightly during luteal-phase mimic (e.g., cycle days 14–28) or in some cases continuous 200 mg for 10–14 days to arrest bleeding, then transition to cyclic dosing.
• For severe menorrhagia: an initial “reset” phase of higher-dose luteal progesterone for 2–3 cycles may be necessary to normalize endometrial shedding.
• Rationale: Progesterone induces secretory transformation, downregulates estrogen receptors, and modulates endometrial MMP activity; cyclical schedules respect the endometrial clock while avoiding excessive continuous progestin exposure that can cause breakthrough bleeding.

Adjuncts that help

• Iron repletion and thyroid normalization to support hemostasis and energy.
• Anti-inflammatory nutrition (omega-3s, curcumin) to reduce prostaglandin excess.
• Integrative chiropractic fit: pelvic alignment and lumbosacral mechanics influence uterine blood flow and cramping; sacroiliac and lumbar adjustments plus neuromuscular re-education can decrease pelvic floor hypertonicity and dysmenorrhea.

PCOS: Insulin, SHBG, and Endometrium—A Systems View

Core physiology

• PCOS often features insulin resistance, ovarian theca hyperandrogenism, and low SHBG, promoting free androgen excess and anovulatory cycles. The endometrium sees prolonged estrogenic stimulation without adequate progesterone—setting up heavy, irregular bleeding.

Evidence-aligned strategies

• Lifestyle: resistance training to increase GLUT4 and insulin sensitivity; protein-forward, fiber-rich dietary patterns; sleep optimization. These steps raise SHBG over time and lower free androgens.
• Cyclic progesterone to ensure regular endometrial shedding and bleeding control.
• Inositol (myo- and D-chiro), vitamin D optimization, and omega-3s have supportive evidence for ovulatory function and metabolic health.
• Consider metformin or GLP-1 receptor agonists when indicated; weight reduction improves ovulation and reduces endometrial risk.

Post-Bariatric Physiology: Absorption Matters

Clinical reality

• After gastric bypass, altered acid production and bypassed segments reduce absorption of iron, B12, folate, fat-soluble vitamins, and sometimes oral hormones/supplements.

My approach

• Use forms with superior bioavailability (e.g., iron bisglycinate, sublingual, or parenteral B12).
• Test, don’t guess: monitor micronutrients and adjust dosing; if oral iron fails, consider IV iron.
• Probiotics: choose strains designed to survive transit to the lower bowel (e.g., spore-formers such as Bacillus species) when proximal absorption is limited. This supports bile acid metabolism and the balance of estrogen deconjugation via the estrobolome.
• Integrative chiropractic fit: vagal stimulation through breathing and cervical/thoracic mobility work can improve motility and reduce post-surgical dyspepsia; gentle core stabilization helps abdominal wall function without overstraining surgical sites.

Testosterone Therapy: Absorption, Distribution, and Excretion—Why Doses Differ

Three-compartment reasoning

• Absorption: For pellets and transdermals, uptake depends on cutaneous blood flow and capillary density. Higher cardiac output and regular exercise increase perfusion, often producing steadier levels and faster onset after implantation.
• Distribution: Testosterone distributes according to lean mass and total body water; greater body mass dilutes peak concentrations. After significant weight loss, the same dose may result in higher effective exposure because there is less tissue volume available for distribution.
• Excretion: Testosterone metabolites are cleared renally. Older patients or those with reduced GFR clear more slowly, prolonging duration. In practice, men in their 70s–80s often maintain target levels from a single pellet insertion for 6–9 months, necessitating lower dosing or longer intervals.

Practical dosing implications

• Recent weight loss (e.g., 20% reduction in body fat): reassess dosing downward; expect stronger response to prior doses.
• Reduced kidney function: extend dosing interval or lower dose due to slower clearance.
• High training load: potentially higher early absorption; confirm with midpoint labs rather than front-loading doses.
• Integrative chiropractic fit: programming resistance training and movement hygiene with hormone therapy accelerates lean mass accrual and improves insulin sensitivity. We pair spine-safe compound lifts, gait retraining, and mobility to reduce injury during anabolic windows.

Transient Estrogenic Symptoms in Men on Testosterone: What Works and Why

The clinical picture

• Some men experience transient nipple sensitivity or breast tenderness shortly after initiating therapy due to acute rises in estradiol from aromatization.

Evidence-based handling

• Time and monitoring: symptoms typically occur after the first treatment and resolve as levels stabilize. Routine use of aromatase inhibitors is discouraged due to adverse effects on lipids, mood, and bone.
• Consider diindolylmethane (DIM) and cruciferous intake to support estrogen metabolism via phase I/II pathways; benefits are modest and best as adjuncts.
• Reassess dose and interval if persistent. Optimize sleep, reduce alcohol (which increases aromatase), and address central adiposity.
• Guard against “dose chasing”: requests for “extra sessions” without clinical rationale often correlate with gym culture expectations rather than endocrine need. Overdosing can worsen erectile quality via supraphysiologic estradiol or HPTA suppression.

SHBG: The Hidden Lever in Midlife Women

Why SHBG matters

• SHBG binds testosterone and estradiol; high SHBG levels lower free fractions and blunt symptom relief. Oral estrogens and certain medications increase SHBG; insulin resistance and androgens lower it.

Clinical vignette logic

• A 45-year-old not needing contraception but on an oral contraceptive for symptoms may present with high SHBG (e.g., 100+ nmol/L) and poor response to physiologic testosterone dosing. Transitioning to non-oral contraception (e.g., a levonorgestrel IUD) removes oral estrogen’s hepatic first-pass upregulation of SHBG, freeing bioactive hormones.
• Strategy:
  • Clarify the indication for OCPs (birth control vs symptom management).
  • If contraception is needed, choose options with minimal SHBG impact (IUDs, implants).
  • For symptom treatment, use transdermal estradiol and oral micronized progesterone, tailoring doses to clinical response and free hormone calculations.

Risk-Benefit Framing: Contraceptives, DVT, and Age

Key points

• In younger women, combined oral contraceptives (COCs) carry a small but real increase in venous thromboembolism (VTE) risk; in women over 40–45, baseline thrombotic risk increases, shifting the risk-benefit calculus, especially when contraception is not needed.
• If a 45-year-old cannot become pregnant (e.g., tubal ligation, IUD in place), using COCs for non-contraceptive reasons is often not optimal due to VTE and stroke risk when safer alternatives exist for PMS, endometriosis, or heavy bleeding (e.g., cyclic progesterone, levonorgestrel IUD, tranexamic acid when appropriate).

Bioidentical Progesterone vs Contraceptive Progestins: Different Tools, Different Jobs

Understanding terms

• Bioidentical progesterone (micronized) is molecularly identical to ovarian progesterone. It supports sleep, anxiolysis (via GABA-A modulation), and endometrial differentiation.
• Progestins (synthetic progestogens) are designed primarily for contraception, with variable androgenic, glucocorticoid, and mineralocorticoid activity. They prevent ovulation and alter cervical mucus but may have different metabolic profiles.

Why this matters clinically

• For symptom treatment in peri/menopause (insomnia, anxiety, heavy bleeding), bioidentical progesterone is often preferred due to favorable neurosteroid effects and endometrial physiology.
• For contraception, progestins are usually more effective at suppressing ovulation. Choice hinges on the therapeutic goal: prevent pregnancy vs. treat symptoms.

Erectile Dysfunction, Arrhythmias, and Testosterone: Untangling Associations

Clinical clarification

• Hypogonadism and erectile dysfunction (ED) share cardiometabolic roots (endothelial dysfunction, insulin resistance). Normalizing testosterone can improve sexual function partly by enhancing nitric oxide signaling and lean mass.
• The presence of atrial fibrillation or a cardioversion plan is not, by itself, a contraindication to physiological testosterone replacement when hypogonadism is documented. Some data suggest that normal testosterone status is associated with better cardiometabolic metrics; however, therapy must be individualized with cardiovascular oversight.

Hematology and Safety

• Monitor hemoglobin and hematocrit. In my clinic, mid-normal testosterone targets with regular phlebotomy only when indicated have maintained hemoglobin safely. Hemoglobin levels in the 40s percent for hematocrit are generally acceptable; vigilance increases as hematocrit approaches upper lab limits.

Beyond SHBG Supplements: Expectations vs Reality

• Numerous supplements claim to lower or raise SHBG. In practice, most shift SHBG by 10–15%, which rarely sufficiently transforms free hormone to resolve symptoms on its own.
• Root-cause moves—reducing oral estrogens, improving insulin sensitivity through strength training and nutrition, addressing thyroid and liver health—produce more durable changes.

Integrative Chiropractic Care: The Biomechanical-Endocrine Bridge

Why biomechanics influence hormones

• Autonomic balance: Spinal and rib mechanics affect respiratory efficiency and vagal tone. Improved parasympathetic activity supports digestion, absorption, sleep quality, and HPA axis resilience.
• Pain reduction lowers cortisol load, helping sex hormones act unopposed by chronic stress signals.
• Strength and alignment: Efficient movement patterns enable productive resistance training, the most potent non-pharmacologic lever for optimizing insulin sensitivity and SHBG.

What we do in practice

• Thoracic outlet and ribcage mobilization to enhance breathing mechanics and vagal tone.
• Lumbopelvic adjustments and pelvic floor coordination to reduce dysmenorrhea and pelvic congestion.
• Progressive resistance programming aligned with hormone cycles: higher-load days during progesterone-stable windows; deload when initiating or changing androgen therapy to reduce injury risk.
• Gait and foot mechanics: improving ground force transmission boosts training capacity, amplifying the anabolic effects of optimized hormones.

Putting It Together: Decision Pathways I Use

For heavy periods with fatigue

• Test iron panel, thyroid function, and, if complex, copper/ceruloplasmin.
• Initiate cyclic oral micronized progesterone to reduce bleeding.
• Replete iron with well-tolerated forms; leverage alternate-day dosing.
• Address pelvic mechanics, breathing, and stress management to improve autonomic tone and absorption.

For PCOS with irregular cycles

• Build a resistance training plan and protein-forward nutrition.
• Add inositols and vitamin D; consider metformin/GLP-1 as indicated.
• Use cyclic progesterone to protect the endometrium.
• Choose a contraception that does not excessively raise SHBG if contraception is needed.

For men starting testosterone

• Educate on transient breast tenderness and why we avoid routine aromatase inhibitors.
• Reassess dose after weight change; monitor renal function and timing of pellet reinsertions.
• Combine with structured strength work; correct movement faults to prevent injury during anabolic phases.

For midlife women on OCPs with high SHBG and low response

• Clarify if contraception is needed. If not, discontinue OCPs and treat symptoms with transdermal estradiol and oral micronized progesterone as appropriate.
• If contraception is needed, consider a levonorgestrel IUD to reduce hepatic SHBG upregulation.
• Reassess free hormone levels after changes; adjust carefully.

Clinical Observations from My Practice

• Addressing the iron-thyroid-copper triad up front accelerates symptom relief and reduces the “two-steps-forward, one-step-back” cycle.
• Patients fare better when we synchronize biomechanical care and hormone adjustments—sleep improves, training quality rises, and fewer dose escalations are needed.
• SHBG is a leading reason for “I don’t feel it” cases; changing the delivery route of estrogen or the contraceptive method often unlocks progress.
• Post-bariatric patients succeed when we adopt a “test, tailor, and tolerate” mindset: verify absorption, pivot to IV when needed, and leverage spore-based probiotics.

Key Takeaways You Can Use Today

• Stabilize the bleed, then replete the iron. Consider copper and thyroid.
• Use cyclic progesterone to organize the endometrium and reduce menorrhagia.
• Dose testosterone with the ADE framework: absorption, distribution, excretion.
• Respect SHBG: route and indication of hormones/contraceptives matter.
• Leverage integrative chiropractic care to enhance autonomic tone, absorption, and training capacity.
• Strength training is medicine: it appropriately elevates SHBG, improves insulin sensitivity, and multiplies the benefits of hormone therapy.

---

References

• Iron metabolism and the role of ceruloplasmin (Anderson & Frazer, 2021). Nature Reviews Disease Primers.
• Hepcidin and iron absorption dynamics (Nemeth & Ganz, 2022). New England Journal of Medicine.
• Thyroid dysfunction and anemia (Cappellini et al., 2020). Journal of the Endocrine Society.
• Micronized progesterone for abnormal uterine bleeding (Prior, 2019). Journal of Clinical Endocrinology & Metabolism.
• PCOS management and lifestyle interventions (Teede et al., 2019). BMJ.
• Post-bariatric micronutrient guidelines (Parrott et al., 2017). Obesity Surgery.
• Testosterone therapy pharmacokinetics and safety (Bhasin et al., 2018). Journal of Clinical Endocrinology & Metabolism.
• Aromatase inhibitor risks in men on TRT (Finkelstein et al., 2013). The Journal of Urology.
• SHBG regulation and clinical implications (Hammond, 2018). Endocrine Reviews.
• Contraceptives and VTE risk (Dragoman et al., 2018). The Lancet.